Inflammatory bowel disease (IBD) is a term referring to gastrointestinal chronic inflammatory disorders. Ulcerative Colitis (UC) and Crohn's Disease (CD) are the two main types of IBD. The aetiology of such disease has been attributed to many factors: aside from the influence of the environment, genetic factors in particular play a significant role in disease progression. Genetic variants C1672T (SLC22A4), G-207C (SLC22A5) G113A, C4136A, 35delA (DLG5) and (rs1799964) TNF-α have been reported to have significant associations with the development of IBD in various populations.

High-volume polyethylene glycol (PEG) is widely used for bowel preparation, but its large volume and unpleasant taste are common drawbacks. These factors frequently lead to reduced patient adherence. Linaclotide, an FDA-approved drug for constipation, appears to offer a potential solution by lowering the amount of PEG needed.

Patients with stage IV colorectal cancer (CRC) with liver metastasis represent a specific group that can be treated with surgery. However, the influence of genomic alterations on the therapeutic response and prognosis was not clear in CRC patients underwent simultaneous surgery of primary and metastatic lesions.

Colorectal cancer (CRC) is a leading cause of cancer-related death, with strong environmental associations and genetic risk factors. Although some microorganisms have been linked to carcinogenesis in CRC, the prevalence of parasites and their potential role in carcinogenesis remain unclear. This study aimed to determine the prevalence and association of the parasites Blastocystis, Cryptosporidium, and Strongyloides in CRC.

Stress granule (SG) regulators affect tumor progression in patients with gastric cancer (GC). This study aimed to explore the effects of SG-related genes on the prognosis, immune characteristics, and drug sensitivity of patients with GC.

Periampullary diverticula (PAD), often detected incidentally during imaging or endoscopy, has been linked to pancreaticobiliary diseases. Previous studies focusing on ERCP patients may overestimate PAD prevalence and its association with these diseases. This study aimed to explore the relationship between PAD characteristics, including size and type, and the occurrence of pancreaticobiliary diseases.

HELICOBACTER PYLORI (H. PYLORI) identified in 1982, infects more than half of the world's population and is a major cause of gastrointestinal issues like gastritis, peptic ulcers, and an elevated risk of stomach cancer. The infection triggers chronic gastritis through the immune response and bacterial toxins such as VacA and CagA, which harm the stomach lining. This persistent inflammation can lead to peptic ulcers by compromising the protective mucous barrier, allowing stomach acid to create lesions. Prolonged infection with more aggressive strains increases the likelihood of gastric cancer by sustaining inflammation and causing genetic changes in stomach cells. Various symptoms related to gastric inflammation include upper abdominal discomfort, bloating, loss of appetite, nausea, and heartburn. The conventional treatment involves a triple therapy regimen combining Rabeprazole, Amoxicillin, and Clarithromycin with the effectiveness of 10-day versus 14-day courses. However, these treatments come with major drawbacks such as quick elimination of a drug from gastrointestinal tract, short half-life and drug resistance. To overcome all these challenges, there is a need for an alternative approach to deliver drugs. In this review, the pathophysiology of H. PYLORI along with its relationship with gut microbe has been discussed. Further, it also includes conventional treatment, its drawbacks and alternative treatment approaches available. Additionally, it also discussed about various clinical trials that have been reported for the treatment of H. PYLORI.

This study investigates the therapeutic potential of Ruta graveolens, a dicot herb known for its antioxidant properties, in protecting against oxidative stress and liver fibrosis caused by bile duct ligation (BDL). The research focused on assessing the biochemical and histological effects of Ruta graveolens extract on male Wistar rats subjected to BDL.

There is no approved medication to rescue fat build-up in patients with nonalcoholic fatty liver disease (NAFLD). Some medications have been used to reduce the symptoms of these patients. In the present study, we aimed to investigate the effects of a gluten-free diet (GFD) on hepatic steatosis (HS), the lipid profile, blood pressure (BP), fasting blood sugar (FBS) and anthropometric indices in patients with NAFLD within 3 months of intervention.

The optimal timing for laparoscopic cholecystectomy following percutaneous cholecystostomy remains a subject of considerable debate, and there is conflicting evidence regarding its impact on clinical outcomes. The aim of this retrospective study is to provide evidence-based insights to optimize the management of gallbladder diseases by comparing early versus delayed cholecystectomy after initial percutaneous drainage.

The study aimed to investigate the effect of rebamipide quadruple therapy combined with gastrointestinal endoscopy on gastrointestinal hormones in patients with gastric ulcer bleeding.

Nonalcoholic fatty liver disease (NAFLD) is a prevalent chronic liver condition worldwide. Although forkhead box O4 (FOXO4) is implicated in liver diseases, its role in NAFLD remains unclear.

Perianal gouty tophi represent a common condition manifesting in a rare site. Due to its rarity in clinical practice, this condition is highly prone to misdiagnosis and inappropriate treatment. This paper presents a detailed report of a middle-aged male patient who was misdiagnosed with perianal abscess. We performed a resection of the perianal mass and debridement and drainage under spinal anesthesia, and the subsequent histopathological examination clearly confirmed the diagnosis of perianal tophi. Conclusion: the perianal masses can also be caused by gout. Although the perianal area is not a common site for tophus formation, in such cases, it is difficult to clearly determine that gout is the cause through common imaging methods such as magnetic resonance imaging (MRI) or ultrasound.

Incidence of ulcerative colitis (UC) is on the rise globally, highlighting the need for new diagnostic methods to alleviate UC burden.

Patients diagnosed with colon cancer after a bleeding episode are often receiving antithrombotic therapy (AT), indicating a potential link between AT and the timing of diagnosis. Our study aims to investigate the possibility that the administration of AT contributes, through the early onset of symptoms, to the early diagnosis of colon cancer.

Optimizing polyp detection, in particular the right-sided colon polyps, is a challenge for endoscopists. This study aimed to evaluate the diagnostic value of LCI combined with CAD EYE in the detection and characterization of right-sided colon polyps.

Prolonged or inappropriate use of total parenteral nutrition (TPN) may lead to the development of intestinal failure-associated liver disease (IFALD), which causes significant morbidity in TPN recipients. However, the underlying mechanism remains unclear.

Inflammatory bowel disease (IBD) is a chronic inflammatory condition that impacts many aspects of patients' lives and requires proper control to improve health outcomes. This study aimed to assess perceived IBD control and identify factors associated with it.

A 64-year-old woman presented with abdominal pain, upper gastrointestinal bleeding, and purpura on her face and extremities. She had previously been treated with mesalazine for ulcerative colitis. Tests revealed anaemia, elevated inflammatory markers (erythrocyte sedimentation rate, 82 mm/h; C-reactive protein concentration, 13.05 mg/dL), and a high proteinase 3-specific antineutrophil cytoplasmic antibody level (94.8 U/mL). Computed tomography showed oedematous thickening of the intestinal wall from the ascending colon to the sigmoid colon. Colonoscopy revealed inflammation of the leukocytoclastic vasculitis, consistent with granulomatosis with polyangiitis mucosa, and the sigmoid colon had various ulcers with mucosal inflammation. Skin biopsy revealed leukocytoclastic vasculitis, indicative of granulomatosis with polyangiitis. Prednisolone (40 mg/day) and tacrolimus (4 mg) resolved the symptoms. To our knowledge, this is the first report of successful tacrolimus therapy for ulcerative colitis complicated by granulomatosis with polyangiitis.